Offerings // BioStem Technologies, Inc.

BSEM offering history

Every offering-related filing in BioStem Technologies, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 75 filings back to Feb 1, 2016.

Last executed offering

Sep 30, 2026

8-K — priced deal (shares or notes)

Last registration (announced)

Oct 2, 2026

S-1 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Oct 13, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 9, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 2, 2026	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Sep 30, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Sep 29, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 29, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 18, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Sep 18, 2026	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Aug 14, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 13, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 11, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 7, 2026	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jul 29, 2026	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Oct 28, 2025	RW →	WITHDRAWN	Registration withdrawn

BSEM offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full BSEM workspace →

BSEM offering FAQ

When did BSEM last execute an offering?

Per SEC filings, BioStem Technologies, Inc.'s most recent priced offering document is a 8-K filed 2026-09-30. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did BSEM last announce or register an offering?

The most recent registration is a S-1 filed 2026-10-02. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.